Toward Monitoring and Addressing the Commercial Determinants of Health: Where Can We Go From Here?
Policy Points We describe ways to advance two key priorities related to the commercial determinants of health (CDH): the development of systems to monitor commercial practices and the creation of policy recommendations to address the CDH. Specifically, we discuss corporate nonfinancial reporting as a potential mechanism to obtain data on commercial practices that influence population health, describe the potential risks and benefits, and propose opportunities to advance high-quality corporate reporting on health impacts. We also review previous global agenda-setting exercises to suggest five key considerations to inform the World Health Organization's forthcoming policy recommendations for addressing the CDH.
Authors
- Christine Lin (ORCID: https://orcid.org/0000-0001-6470-2712)
- Nicholas Freudenberg (ORCID: https://orcid.org/0000-0001-5159-6914)
- Tanja Srebotnjak
- Lawrence Grierson (ORCID: https://orcid.org/0000-0003-0739-5976)
- Raquel Burgess (ORCID: https://orcid.org/0000-0003-3131-366X)
- Daniel C. Esty (ORCID: https://orcid.org/0000-0001-9980-1147)
- Yusuf Ransome (ORCID: https://orcid.org/0000-0003-4170-2001)
Institutions
- City University of New York (US)
- Williams College (US)
- Yale University (US)
- McMaster University (CA)
Publication Details
- Journal
- Milbank Quarterly
- Published
- 2025-05-25
- DOI
- https://doi.org/10.1111/1468-0009.70012
- Citations
- 2
- Primary Topic
- Global Public Health Policies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 5.53